Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544530 · ClinicalTrials.gov registry record · Phase 2
Cooling to Optimize Organ Life in Donor Study
A Phase 2 study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT01544530 is a Phase 2 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 4 participants.
The verdict
NCT01544530, a Phase 2 study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the feasibility and safety of mild-to-moderate hypothermia as an in-vivo organ preservation strategy compared to normothermia in 60 brain-dead organ donors.
Interventions
- OTHER Cold isotonic fluid and central venous hypothermia catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01544530
The ClinicalTrials.gov registry entry for NCT01544530 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cold isotonic fluid and central venous hypothermia catheter is the first listed.
NCT01544530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01544530 about?
NCT01544530 is a clinical study titled "Cooling to Optimize Organ Life in Donor Study". The purpose of this study is to assess the feasibility and safety of mild-to-moderate hypothermia as an in-vivo organ preservation strategy compared to normothermia in 60 brain-dead organ donors.
What is the current status of trial NCT01544530?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2012-03. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01544530?
The interventions under investigation include: Cold isotonic fluid and central venous hypothermia catheter (OTHER).
Who is sponsoring clinical trial NCT01544530?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.